[
  {
    "ts": null,
    "headline": "Merck: Don't Fight The Tape, How Low Can It Go?",
    "summary": "Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines. Click for more on MRK Q4 earnings.",
    "url": "https://finnhub.io/api/news?id=8efcc3c20d2667e09cec883be62478cd5f14ac891b3fb1081d4de29b57f647f9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738776499,
      "headline": "Merck: Don't Fight The Tape, How Low Can It Go?",
      "id": 132568610,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155351397/image_155351397.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines. Click for more on MRK Q4 earnings.",
      "url": "https://finnhub.io/api/news?id=8efcc3c20d2667e09cec883be62478cd5f14ac891b3fb1081d4de29b57f647f9"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 140-point fall led by losses for shares of UnitedHealth, Merck",
    "summary": "Dow's 140-point fall led by losses for shares of UnitedHealth, Merck",
    "url": "https://finnhub.io/api/news?id=4324f4aab5bdee985d884c706306d687c634c2961275b19c4569ef331412e62c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738749780,
      "headline": "Dow's 140-point fall led by losses for shares of UnitedHealth, Merck",
      "id": 132564102,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow's 140-point fall led by losses for shares of UnitedHealth, Merck",
      "url": "https://finnhub.io/api/news?id=4324f4aab5bdee985d884c706306d687c634c2961275b19c4569ef331412e62c"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Presents An Opportunity After LIBTAYO Sales Growth Bolsters Earnings",
    "summary": "Regeneron's Q4 earnings report shows revenue growth, stable EYLEA sales, dividend announcement, and impressive growth for LIBTAYO in 2024. Read more here.",
    "url": "https://finnhub.io/api/news?id=6d053d8b0c2de44e8e9fd79d0e6f7e54589c26a8066a4091d94f87302426f94f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738741500,
      "headline": "Regeneron Presents An Opportunity After LIBTAYO Sales Growth Bolsters Earnings",
      "id": 132561931,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962536/image_1386962536.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Regeneron's Q4 earnings report shows revenue growth, stable EYLEA sales, dividend announcement, and impressive growth for LIBTAYO in 2024. Read more here.",
      "url": "https://finnhub.io/api/news?id=6d053d8b0c2de44e8e9fd79d0e6f7e54589c26a8066a4091d94f87302426f94f"
    }
  },
  {
    "ts": null,
    "headline": "Merck Is Suffering From a Classic Pharma Problem",
    "summary": "Merck Is Suffering From a Classic Pharma Problem",
    "url": "https://finnhub.io/api/news?id=9c176806575301aa39a2825c11115e2067f62d0cadf52008873bf924f3d6328e",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738738800,
      "headline": "Merck Is Suffering From a Classic Pharma Problem",
      "id": 132564431,
      "image": "",
      "related": "MRK",
      "source": "DowJones",
      "summary": "Merck Is Suffering From a Classic Pharma Problem",
      "url": "https://finnhub.io/api/news?id=9c176806575301aa39a2825c11115e2067f62d0cadf52008873bf924f3d6328e"
    }
  }
]